HMG-CoA reductase inhibitors (statins) versus placebo for people with schizophrenia.

ABSTRACT:

Objectives

This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To evaluate the benefits and harms of HMG-CoA reductase inhibitors (statins) compared with placebo for schizophrenia in adults.

SUBMITTER: Saishoji Y 

PROVIDER: S-EPMC12447392 | biostudies-literature | 2025 Sep

REPOSITORIES: biostudies-literature